【4503】アステラス製薬 : FDA ACCEPTS SUPPLEMENTAL NEW DRUG APPLICATION FOR TARCEVA (ERLOTINIB) TABLETS FOR GENETICALLY DISTINCT FORM OF ADVANCED LUNG CANCER

FDA ACCEPTS SUPPLEMENTAL NEW DRUG APPLICATION FOR TARCEVA (ERLOTINIB) TABLETS FOR GENETICALLY DISTINCT FORM OF ADVANCED LUNG CANCER

出所:株経通信(株式会社みんかぶ)
PDFをダウンロード